342 related articles for article (PubMed ID: 26528286)
1. Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate.
Meirow Y; Kanterman J; Baniyash M
Front Immunol; 2015; 6():523. PubMed ID: 26528286
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy.
Baniyash M
Cancer Immunol Immunother; 2016 Jul; 65(7):857-67. PubMed ID: 27225641
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation and cancer: suppressing the suppressors.
Baniyash M; Sade-Feldman M; Kanterman J
Cancer Immunol Immunother; 2014 Jan; 63(1):11-20. PubMed ID: 23990173
[TBL] [Abstract][Full Text] [Related]
5. The immunobiology of myeloid-derived suppressor cells in cancer.
Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
[TBL] [Abstract][Full Text] [Related]
6. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
Salminen A; Kaarniranta K; Kauppinen A
Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
[TBL] [Abstract][Full Text] [Related]
7. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
8. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
[TBL] [Abstract][Full Text] [Related]
9. Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy.
Wang Y; Jia A; Bi Y; Wang Y; Yang Q; Cao Y; Li Y; Liu G
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32942545
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
Yin Z; Li C; Wang J; Xue L
Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.
Yin K; Xia X; Rui K; Wang T; Wang S
Front Oncol; 2020; 10():610104. PubMed ID: 33384962
[TBL] [Abstract][Full Text] [Related]
12. Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review).
Musolino C; Allegra A; Pioggia G; Gangemi S
Oncol Rep; 2017 Feb; 37(2):671-683. PubMed ID: 27922687
[TBL] [Abstract][Full Text] [Related]
13. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment.
Jou E; Chaudhury N; Nasim F
Explor Target Antitumor Ther; 2024; 5(1):187-207. PubMed ID: 38464388
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
17. The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression.
Umansky V; Blattner C; Gebhardt C; Utikal J
Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27827871
[TBL] [Abstract][Full Text] [Related]
18. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
[TBL] [Abstract][Full Text] [Related]
19. Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
Srivastava MK; Zhu L; Harris-White M; Huang M; St John M; Lee JM; Salgia R; Cameron RB; Strieter R; Dubinett S; Sharma S
Immunotargets Ther; 2012 Oct; 2012(1):7-12. PubMed ID: 24791250
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
